The FDA on Tuesday approved etuvetidigene autotemcel (Waskyra) as the first cell-based gene therapy for patients 6 months and ...

The New York Blood Center (NYBC) opened its first-ever donor center based in Queens, marking a milestone for the organization ...

Bavier joins Sudo from norovirus vaccine developer HilleVax, where he was GC and chief administrative officer. He brings more ...

Chicago's Lurie's Children's Hospital will expand care for patients living with rare genetic diseases and conditions thanks ...

A new University of California San Diego School of Medicine study offers a unified biological model to explain how genetic predispositions and environmental exposures converge to cause autism spectrum ...

A new University of California San Diego School of Medicine study offers a unified biological model to explain how genetic predispositions and environmental exposures converge to cause autism spectrum ...

Christie Innomed Inc., a leader in medical imaging and health technologies, announces that Dr. Michel Vachon and Nicolas Vachon have acquired all the shares of Group Christie and its subsidiaries.

Trust AI announced today that Isaac OneHealth, the clinical AI platform transforming dental practice, has achieved a perfect 100% score on the most challenging questions from the United States Medical ...

New Cancer Therapy Brings Remission For Patients With Deadly T-Cell Leukaemia. A small group of patients with an otherwise incurable form of T‐cell leukaemia have seen their cancer driven into ...

BioNJ CEO Debbie Hart discusses New Jersey’s life sciences growth, state investment, industry challenges and how BioNJ is ...

An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly ...

AN ENLIGHTENING session, entitled ‘Emerging therapeutic frontiers in cardiology: what does the future hold?’, delivered at ...